Table 6.
CON-EX |
GLY-EX |
|||||
---|---|---|---|---|---|---|
Rest | 25% | 50% | Rest | 25% | 50% | |
Heart rate, beats/min | ||||||
Men | 63 ± 8 | 95 ± 10† | 122 ± 16†‡ | 109 ± 9a | 127 ± 13†a | 151 ± 15†‡a |
Women | 61 ± 10 | 96 ± 8† | 122 ± 12†‡ | 108 ± 15a | 126 ± 15†a | 145 ± 16†‡a |
Mean arterial pressure, mmHg | ||||||
Men | 89 ± 7 | 96 ± 7† | 103 ± 8†‡ | 88 ± 7 | 89 ± 9 | 95 ± 8†‡ |
Women | 77 ± 8* | 85 ± 7*† | 91 ± 9*†‡ | 82 ± 10* | 80 ± 6* | 87 ± 9*†‡ |
End-diastolic volume, ml | ||||||
Men | 136 ± 18 | 143 ± 20† | 144 ± 21† | 125 ± 16 | 128 ± 19† | 130 ± 18† |
Women | 109 ± 15* | 118 ± 18*† | 119 ± 17*† | 106 ± 15* | 113 ± 18*† | 118 ± 20†‡ |
End-diastolic volume, ml/m | ||||||
Men | 49 ± 7 | 54 ± 7† | 53 ± 8† | 46 ± 7 | 48 ± 7 | 49 ± 6† |
Women | 47 ± 4 | 52 ± 5† | 52 ± 5† | 46 ± 5 | 49 ± 6† | 51 ± 5†‡ |
End-systolic volume, ml | ||||||
Men | 63 ± 9 | 59 ± 10 | 57 ± 9†‡ | 64 ± 8 | 58 ± 10† | 56 ± 11† |
Women | 49 ± 9* | 47 ± 8*† | 44 ± 10*† | 51 ± 8* | 50 ± 10* | 49 ± 10 |
End-systolic volume, ml/m | ||||||
Men | 23 ± 3 | 22 ± 3† | 21 ± 3† | 24 ± 3 | 22 ± 3† | 21 ± 3† |
Women | 21 ± 3 | 20 ± 3† | 19 ± 3†‡ | 22 ± 3 | 22 ± 3 | 22 ± 3 |
Stroke volume, ml | ||||||
Men | 73 ± 11 | 83 ± 11† | 87 ± 14†‡ | 60 ± 9 | 70 ± 10† | 74 ± 9†‡ |
Women | 60 ± 7* | 72 ± 12*† | 76 ± 9*†‡ | 55 ± 7 | 63 ± 10*† | 68 ± 12†‡ |
Stroke volume, ml/m | ||||||
Men | 27 ± 5 | 31 ± 4† | 32 ± 6†‡ | 23 ± 5 | 26 ± 3† | 27 ± 3† |
Women | 26 ± 2 | 31 ± 4† | 33 ± 3†‡ | 24 ± 4 | 27 ± 3† | 30 ± 3†‡ |
Ejection fraciton, % | ||||||
Men | 53 ± 3 | 58 ± 2† | 60 ± 3†‡ | 48 ± 2 | 55 ± 3† | 57 ± 4†‡ |
Women | 55 ± 4 | 61 ± 3*† | 64 ± 4*†‡ | 52 ± 3* | 56 ± 3† | 58 ± 4†‡ |
Cardiac output, l/min | ||||||
Men | 4.47 ± 0.39 | 7.87 ± 0.98† | 10.54 ± 1.33†‡ | 6.57 ± 1.00 | 8.82 ± 0.83† | 11.11 ± 0.89†‡ |
Women | 3.66 ± 0.58* | 6.88 ± 1.05*† | 9.23 ± 0.96*†‡ | 5.92 ± 0.91 | 7.87 ± 1.13*† | 9.80 ± 1.40*†‡ |
Total peripheral resistance, mmHg·l−1· min−1 | ||||||
Men | 20.2 ± 2.7 | 12.4 ± 1.7† | 10.0 ± 1.8†‡ | 13.7 ± 2.2 | 10.2 ± 1.4† | 8.6 ± 0.9†‡ |
Women | 21.5 ± 3.2 | 12.6 ± 1.9† | 10.0 ± 1.3†‡ | 14.1 ± 2.8 | 10.3 ± 1.3† | 9.0 ± 1.6†‡ |
Values are means ± SD; n = 17 women and 16 men in the control-exercise (CON-EX) group and 16 women and 17 men in the glycopyrrolate-exercise (GLY-EX) group.
P < 0.05 vs. men;
P < 0.05 vs. rest;
P < 0.05 vs. 25%.
P values derived from 2 (sex) × 3 (exercise) ANOVA examining main effects for sex, exercise level, and interaction (sex × exercise) are provided in Supplemental Table S2.
Data analyzed with nonparametric statistics; medians and interquartile ranges are provided in Supplemental Table S4.